INDIUM IN-111 CHLORIDE STERILE SOLUTION DIN 02329077
Health Canada record
| Active ingredient(s) | INDIUM IN 111 CHLORIDE 74 MBq |
|---|---|
| Dosage form | Solution |
| Route | Intravenous |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | |
| Original market date | |
| Current status date | 02-Sep-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
GE Healthcare Canada Inc. — licence 101469, currently licensed, last inspection rating C (2023-02-06).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing INDIUM IN
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02329271 | OCTREOSCAN | CURIUM CANADA INC | Powder For Solution; Solution; Kit | INDIUM IN 111 CHLORIDE 111 MBq; PENTETREOTIDE 10 MCG | Marketed |
| 02329468 | HIGH PURITY INDIUM CHLORIDE IN 111 STERILE SOLUTION | CURIUM CANADA INC | Solution | INDIUM IN 111 CHLORIDE 10 MCI | Dormant |
| 02329085 | INDIUM IN-111 CHLORIDE STERILE SOLUTION | GE HEALTHCARE CANADA INC | Solution | INDIUM IN 111 CHLORIDE 185 MBq | Cancelled Pre Market |
International API supply for INDIUM IN
1 active FDA Drug Master Files.
Request a quote for INDIUM IN-111 CHLORIDE STERILE SOLUTION